In Research
JDRF Canada and its affiliate partners are leading the international research effort to end type 1 diabetes (T1D).
Here’s how we moved the needle in 2021:
36 cutting-edge projects and clinical trials supported in Canada
nearly $80 million CAD invested in T1D research worldwide
19 countries with active grants – demonstrating the scope of JDRF’s 2021 international research portfolio
50+ clinical trials supported in Canada and around the world to bring new treatments to market faster
60+ new research grants for the world’s most promising studies
275+ active projects
Previous Page
Our Collective Impact: Overview
Next Page
Through Our Advocacy